Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1050 of 2228 entries
View as:

A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT04419506 Org: User:
Start: 07/28/20 End: 10/15/21 Due: 10/15/22

A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03752970 Org: User:
Start: 02/05/19 End: 07/04/22 Due: 07/04/23

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02172118 Org: User:
Start: 08/31/09 End: - Due: -

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02220660 Org: User:
Start: 03/31/09 End: - Due: -

A Study in Healthy Men to Test How BI 1015550 is Taken up and Handled by the Body

Phase: N/A Priority: Normal
NCT ID: NCT05707403 Org: User:
Start: 02/14/23 End: 03/28/23 Due: 03/28/24

Increasing Dose Study of Pramipexole in Two-way Cross-over Comparison of ER Tablet Versus IR Tablet in Japanese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02264132 Org: User:
Start: 09/30/06 End: - Due: -

A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT03802331 Org: User:
Start: 01/28/19 End: 03/03/19 Due: 03/03/20

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00819052 Org: User:
Start: 12/31/08 End: 01/31/12 Due: 01/31/13

The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database Analysis

Phase: N/A Priority: Normal
NCT ID: NCT03026556 Org: User:
Start: 12/29/16 End: 08/23/17 Due: 08/23/18

Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food

Phase: N/A Priority: Normal
NCT ID: NCT01189201 Org: User:
Start: 08/31/10 End: - Due: -

Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

Phase: N/A Priority: Normal
NCT ID: NCT04138758 Org: User:
Start: 11/01/19 End: 11/04/19 Due: 11/04/20

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Phase: N/A Priority: Normal
NCT ID: NCT03165227 Org: User:
Start: 10/17/17 End: 12/10/19 Due: 12/10/20

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Phase: N/A Priority: Normal
NCT ID: NCT01399619 Org: User:
Start: 09/30/11 End: 06/30/14 Due: 06/30/15

Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172209 Org: User:
Start: 01/31/08 End: - Due: -

Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02182284 Org: User:
Start: 01/31/08 End: - Due: -

Afatinib Expanded Access Program

Phase: N/A Priority: Normal
NCT ID: NCT01649284 Org: User:
Start: 07/31/12 End: 03/31/14 Due: 03/31/15

Pharmacokinetics, Safety and Pharmacodynamics After Multiple Oral Doses of Dabigatran Etexilate Capsule in Healthy Japanese and Caucasian Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02171468 Org: User:
Start: 05/31/06 End: - Due: -

Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China

Phase: N/A Priority: Normal
NCT ID: NCT03064841 Org: User:
Start: 03/09/17 End: 12/30/17 Due: 12/30/18

PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

Phase: N/A Priority: Normal
NCT ID: NCT00936208 Org: User:
Start: 05/31/09 End: - Due: -

Evaluation of the Effects of Pharmaton Tablets on Mental Performance and Physical Fatigue in Nurses Working Night Shift

Phase: N/A Priority: Normal
NCT ID: NCT02199847 Org: User:
Start: 06/30/00 End: - Due: -

Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00844194 Org: User:
Start: 02/28/09 End: - Due: -

Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214953 Org: User:
Start: 10/31/07 End: - Due: -

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Phase: N/A Priority: Normal
NCT ID: NCT05512377 Org: User:
Start: 12/13/22 End: 10/20/25 Due: 10/20/26

Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00613314 Org: User:
Start: 06/30/07 End: - Due: -

Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00144300 Org: User:
Start: 01/31/05 End: - Due: -